US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD

2.28

-0.1300-5.39%

Post-market: 2.20-0.0786-3.45%16:42 EDT

Volume:48.70K

Turnover:111.14K

Market Cap:32.97M

PE:-0.61

High:2.44

Open:2.37

Low:2.19

Close:2.41

52wk High:16.25

52wk Low:2.04

Shares:14.46M

Float Shares:12.01M

Volume Ratio:0.43

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7150

EPS(LYR):-3.7150

ROE:-174.71%

ROA:-49.84%

PB:1.86

PE(LYR):-0.61

Loading ...

Overview Company News Filings

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial

Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Press Release: Radiopharm Theranostics Reports Business Update

NASDAQ Trade Halt Continues Volatility Trading Pause at 09:37 Am

Radiopharm announces $4.1M registered direct offering

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

NASDAQ Trade Halt Halt News Pending at 07:56 Pm

Radiopharm Theranostics Ltd : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $16

THOMSON REUTERS

Radiopharm initiated with a Buy at H.C. Wainwright

Radiopharm Theranostics Reports Business Update

Radiopharm announces new data from Phase 0/1 HEAT trial

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Analysts Are Bullish on These Healthcare Stocks: Schrodinger (SDGR), Radiopharm Theranostics Limited Sponsored ADR (RADX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/RADX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RADX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RADX\",,,,,undefined,":{"symbol":"RADX","market":"US","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD","latestPrice":2.28,"timestamp":1788206400000,"preClose":2.41,"halted":0,"volume":48703,"hourTrading":{"tag":"盘后","latestPrice":2.2014,"preClose":2.28,"latestTime":"16:42 EDT","volume":57,"amount":126.03000390000001,"timestamp":1788208944923,"change":-0.0786,"changeRate":-0.034474,"amplitude":0.034474},"delay":0,"changeRate":-0.05394190871369308,"floatShares":12005000,"shares":14458500,"eps":-3.714978,"marketStatus":"Post-Mkt","change":-0.13,"latestTime":"08-31 16:59:49 EDT","open":2.37,"high":2.4421,"low":2.185,"amount":111140.099891,"amplitude":0.10668,"askPrice":2.71,"askSize":100,"bidPrice":2.04,"bidSize":180,"shortable":3,"etf":0,"ttmEps":-3.714978,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":300,"exchange":"NASDAQ","adjPreClose":2.41,"preHourTrading":{"tag":"盘前","latestPrice":2.3792,"preClose":2.41,"latestTime":"08:10 EDT","volume":46,"amount":105.72739360000001,"timestamp":1788178249438,"change":-0.0308,"changeRate":-0.01278,"amplitude":0.143734},"postHourTrading":{"tag":"盘后","latestPrice":2.2014,"preClose":2.28,"latestTime":"16:42 EDT","volume":57,"amount":126.03000390000001,"timestamp":1788208944923,"change":-0.0786,"changeRate":-0.034474,"amplitude":0.034474},"volumeRatio":0.426901},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RADX\",,,,,undefined,":{"symbol":"RADX","floatShares":12005000,"roa":"-49.84%","roe":"-174.71%","lyrEps":-3.714978,"volumeRatio":0.426901,"shares":14458500,"dividePrice":0,"high":2.4421,"amplitude":0.10668,"preClose":2.41,"low":2.185,"week52Low":2.0437,"pbRate":"1.86","psRate":"3.64","week52High":16.25,"institutionHeld":0,"latestPrice":2.28,"committee":0.285714,"eps":-3.714978,"divideRate":0,"volume":48703,"delay":0,"ttmEps":-3.714978,"open":2.37,"prevYearClose":5.22,"prevWeekClose":2.41,"prevMonthClose":3.15,"prevQuarterClose":4.19,"fiveDayClose":2.44,"twentyDayClose":3.11,"sixtyDayClose":4.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RADX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RADX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RADX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1780632000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RADX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RADX","date":"2026-08-28","current":-0.592197,"percent":0.920213,"low":-2.495767,"twenty":-1.628255,"median":-1.40486,"eighty":-1.152659,"high":-0.271806,"avg":-1.39781,"sd":0.412828,"marketCap":28080812.11},"quantilePoints":[{"date":"2024-05-31","current":-0.322141,"twenty":-0.346302,"median":-0.337241,"eighty":-0.328181,"marketCap":9781385.7},{"date":"2024-06-07","current":-0.281873,"twenty":-0.336235,"median":-0.302007,"eighty":-0.293953,"marketCap":8486028.31},{"date":"2024-06-14","current":-0.302007,"twenty":-0.326168,"median":-0.302007,"eighty":-0.293953,"marketCap":9131850.7},{"date":"2024-06-21","current":-0.342275,"twenty":-0.338248,"median":-0.302007,"eighty":-0.302007,"marketCap":10381004.78},{"date":"2024-06-28","current":-0.382542,"twenty":-0.348315,"median":-0.302007,"eighty":-0.302007,"marketCap":11671968.91},{"date":"2024-07-05","current":-0.809355,"twenty":-0.41073,"median":-0.332208,"eighty":-0.302007,"marketCap":24962852.9},{"date":"2024-07-12","current":-0.855604,"twenty":-0.818605,"median":-0.342275,"eighty":-0.302007,"marketCap":26579320.02},{"date":"2024-07-19","current":-0.855604,"twenty":-0.850979,"median":-0.352342,"eighty":-0.302007,"marketCap":26173936.05},{"date":"2024-07-26","current":-0.809355,"twenty":-0.855604,"median":-0.40771,"eighty":-0.302007,"marketCap":24246591.55},{"date":"2024-08-02","current":-0.809355,"twenty":-0.855604,"median":-0.809355,"eighty":-0.302007,"marketCap":24110756.3},{"date":"2024-08-09","current":-0.739982,"twenty":-0.850979,"median":-0.751544,"eighty":-0.302007,"marketCap":22251399.26},{"date":"2024-08-16","current":-0.855604,"twenty":-0.850979,"median":-0.763106,"eighty":-0.306034,"marketCap":25968950.02},{"date":"2024-08-23","current":-1.545856,"twenty":-0.855604,"median":-0.809355,"eighty":-0.324154,"marketCap":47995902.64},{"date":"2024-08-30","current":-1.604426,"twenty":-0.878729,"median":-0.809355,"eighty":-0.334221,"marketCap":52075270.43},{"date":"2024-09-06","current":-1.387611,"twenty":-0.878729,"median":-0.809355,"eighty":-0.342275,"marketCap":44469151.18},{"date":"2024-09-13","current":-1.359542,"twenty":-1.344249,"median":-0.809355,"eighty":-0.342275,"marketCap":43759697.93},{"date":"2024-09-20","current":-1.450178,"twenty":-1.387611,"median":-0.820917,"eighty":-0.342275,"marketCap":47180583.53},{"date":"2024-09-27","current":-1.359542,"twenty":-1.40486,"median":-0.83248,"eighty":-0.342275,"marketCap":45125863.21},{"date":"2024-10-04","current":-1.223587,"twenty":-1.40486,"median":-0.855604,"eighty":-0.352342,"marketCap":39830237.61},{"date":"2024-10-11","current":-1.223587,"twenty":-1.387611,"median":-0.855604,"eighty":-0.382542,"marketCap":39633817.47},{"date":"2024-10-18","current":-1.268906,"twenty":-1.387611,"median":-0.878729,"eighty":-0.402676,"marketCap":40804037.96},{"date":"2024-10-25","current":-1.178269,"twenty":-1.359542,"median":-0.878729,"eighty":-0.412743,"marketCap":37457388.45},{"date":"2024-11-01","current":-1.087633,"twenty":-1.359542,"median":-0.878729,"eighty":-0.463078,"marketCap":34300880.03},{"date":"2024-11-08","current":-1.087633,"twenty":-1.359542,"median":-0.960522,"eighty":-0.693733,"marketCap":34332493.75},{"date":"2024-11-15","current":-1.132951,"twenty":-1.359542,"median":-1.087633,"eighty":-0.705295,"marketCap":35106642.11},{"date":"2024-11-22","current":-1.132951,"twenty":-1.344249,"median":-1.087633,"eighty":-0.739982,"marketCap":35229583.66},{"date":"2024-11-29","current":-1.268906,"twenty":-1.347308,"median":-1.098963,"eighty":-0.739982,"marketCap":39624162.16},{"date":"2024-12-06","current":-1.40486,"twenty":-1.347308,"median":-1.132951,"eighty":-0.739982,"marketCap":43039922.69},{"date":"2024-12-13","current":-1.314224,"twenty":-1.359542,"median":-1.178269,"eighty":-0.758481,"marketCap":40045666.62},{"date":"2024-12-20","current":-1.097941,"twenty":-1.359542,"median":-1.178269,"eighty":-0.781606,"marketCap":32921846.04},{"date":"2024-12-27","current":-1.052194,"twenty":-1.350366,"median":-1.132951,"eighty":-0.800105,"marketCap":31363775.33},{"date":"2025-01-03","current":-1.143689,"twenty":-1.332239,"median":-1.132951,"eighty":-0.809355,"marketCap":34031822.64},{"date":"2025-01-10","current":-1.69849,"twenty":-1.338244,"median":-1.132951,"eighty":-0.809355,"marketCap":50037538.71},{"date":"2025-01-17","current":-1.358792,"twenty":-1.359542,"median":-1.13832,"eighty":-0.809355,"marketCap":40487744.22},{"date":"2025-01-24","current":-1.314257,"twenty":-1.359542,"median":-1.160979,"eighty":-0.809355,"marketCap":39844121.78},{"date":"2025-01-31","current":-1.216905,"twenty":-1.358792,"median":-1.178269,"eighty":-0.809355,"marketCap":36388838.79},{"date":"2025-02-07","current":-1.216905,"twenty":-1.358792,"median":-1.178269,"eighty":-0.809355,"marketCap":36546099.84},{"date":"2025-02-14","current":-1.216905,"twenty":-1.344249,"median":-1.178269,"eighty":-0.809355,"marketCap":37113282.66},{"date":"2025-02-21","current":-1.168228,"twenty":-1.320255,"median":-1.178269,"eighty":-0.809355,"marketCap":35712797.58},{"date":"2025-02-28","current":-1.411154,"twenty":-1.320255,"median":-1.178269,"eighty":-0.809355,"marketCap":37675223.82},{"date":"2025-03-07","current":-1.628255,"twenty":-1.359542,"median":-1.178269,"eighty":-0.809355,"marketCap":44128949.39},{"date":"2025-03-14","current":-1.519704,"twenty":-1.365156,"median":-1.178269,"eighty":-0.818605,"marketCap":41272857.77},{"date":"2025-03-21","current":-1.519704,"twenty":-1.40486,"median":-1.200928,"eighty":-0.830167,"marketCap":40977829.82},{"date":"2025-03-28","current":-1.519704,"twenty":-1.408087,"median":-1.216905,"eighty":-0.83248,"marketCap":41148119.25},{"date":"2025-04-04","current":-1.248329,"twenty":-1.408087,"median":-1.216905,"eighty":-0.83248,"marketCap":32359722.11},{"date":"2025-04-11","current":-1.248329,"twenty":-1.405352,"median":-1.216905,"eighty":-0.83248,"marketCap":33413135.19},{"date":"2025-04-17","current":-1.194053,"twenty":-1.40486,"median":-1.216905,"eighty":-0.846354,"marketCap":32759705.88},{"date":"2025-04-25","current":-1.139778,"twenty":-1.40486,"median":-1.216905,"eighty":-0.855604,"marketCap":31306580.22},{"date":"2025-05-02","current":-1.248329,"twenty":-1.40486,"median":-1.208916,"eighty":-0.855604,"marketCap":34593080.94},{"date":"2025-05-09","current":-1.166916,"twenty":-1.40486,"median":-1.194053,"eighty":-0.855604,"marketCap":32202126.03},{"date":"2025-05-16","current":-1.194053,"twenty":-1.394511,"median":-1.194053,"eighty":-0.855604,"marketCap":32809944.41},{"date":"2025-05-23","current":-1.139778,"twenty":-1.387611,"median":-1.194053,"eighty":-0.869479,"marketCap":31441132.85},{"date":"2025-05-30","current":-1.302604,"twenty":-1.376383,"median":-1.194053,"eighty":-0.878729,"marketCap":36099454.15},{"date":"2025-06-06","current":-1.356879,"twenty":-1.40486,"median":-1.194053,"eighty":-0.878729,"marketCap":38067264.48},{"date":"2025-06-13","current":-1.411154,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":39569302.95},{"date":"2025-06-20","current":-1.302604,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":36150708.62},{"date":"2025-06-27","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34052548.6},{"date":"2025-07-03","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34189045.21},{"date":"2025-07-11","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34148653.85},{"date":"2025-07-18","current":-1.209897,"twenty":-1.387611,"median":-1.209897,"eighty":-0.878729,"marketCap":33730235.98},{"date":"2025-07-25","current":-1.264893,"twenty":-1.387611,"median":-1.209897,"eighty":-0.960699,"marketCap":35934358.2},{"date":"2025-08-01","current":-1.264893,"twenty":-1.359542,"median":-1.209897,"eighty":-1.031228,"marketCap":34977710.76},{"date":"2025-08-08","current":-1.319888,"twenty":-1.359542,"median":-1.216905,"eighty":-1.042315,"marketCap":36889892.11},{"date":"2025-08-15","current":-1.429879,"twenty":-1.374883,"median":-1.216905,"eighty":-1.045717,"marketCap":39922534.09},{"date":"2025-08-22","current":-1.484874,"twenty":-1.387611,"median":-1.216905,"eighty":-1.052194,"marketCap":41008050.86},{"date":"2025-08-29","current":-1.539869,"twenty":-1.40486,"median":-1.216905,"eighty":-1.052194,"marketCap":43209517.78},{"date":"2025-09-05","current":-1.804169,"twenty":-1.411154,"median":-1.219048,"eighty":-1.052194,"marketCap":43085813},{"date":"2025-09-12","current":-1.997473,"twenty":-1.411154,"median":-1.223587,"eighty":-1.052194,"marketCap":48781312.13},{"date":"2025-09-19","current":-1.997473,"twenty":-1.411626,"median":-1.223587,"eighty":-1.078841,"marketCap":48506969.7},{"date":"2025-09-26","current":-1.78871,"twenty":-1.434815,"median":-1.223587,"eighty":-1.087207,"marketCap":44899204.58},{"date":"2025-10-03","current":-2.035429,"twenty":-1.465429,"median":-1.242862,"eighty":-1.087633,"marketCap":51388248.5},{"date":"2025-10-10","current":-2.282147,"twenty":-1.474337,"median":-1.248329,"eighty":-1.087633,"marketCap":57333987.03},{"date":"2025-10-17","current":-2.282147,"twenty":-1.484874,"median":-1.248329,"eighty":-1.087633,"marketCap":56871916.68},{"date":"2025-10-24","current":-1.603671,"twenty":-1.496475,"median":-1.264893,"eighty":-1.087633,"marketCap":40034303.67},{"date":"2025-10-31","current":-1.480312,"twenty":-1.496475,"median":-1.264893,"eighty":-1.087633,"marketCap":37196925.09},{"date":"2025-11-07","current":-1.667996,"twenty":-1.508839,"median":-1.264893,"eighty":-1.095879,"marketCap":41344030},{"date":"2025-11-14","current":-1.595475,"twenty":-1.519704,"median":-1.265237,"eighty":-1.097941,"marketCap":40095972.34},{"date":"2025-11-21","current":-1.559214,"twenty":-1.526336,"median":-1.265581,"eighty":-1.097941,"marketCap":38670179.17},{"date":"2025-11-28","current":-1.595475,"twenty":-1.539869,"median":-1.265581,"eighty":-1.097941,"marketCap":39962388.95},{"date":"2025-12-05","current":-1.595475,"twenty":-1.541991,"median":-1.268906,"eighty":-1.097941,"marketCap":40496772.81},{"date":"2025-12-12","current":-1.384154,"twenty":-1.541285,"median":-1.268906,"eighty":-1.097941,"marketCap":35376521.13},{"date":"2025-12-19","current":-1.894105,"twenty":-1.545856,"median":-1.268906,"eighty":-1.105352,"marketCap":48095792.72},{"date":"2025-12-26","current":-2.495767,"twenty":-1.55669,"median":-1.268906,"eighty":-1.119356,"marketCap":64120769.23},{"date":"2026-01-02","current":-2.310895,"twenty":-1.583702,"median":-1.268906,"eighty":-1.132951,"marketCap":59121507.97},{"date":"2026-01-09","current":-2.310895,"twenty":-1.595475,"median":-1.268906,"eighty":-1.132951,"marketCap":59271793.43},{"date":"2026-01-16","current":-2.310895,"twenty":-1.602032,"median":-1.274055,"eighty":-1.134316,"marketCap":59450754.16},{"date":"2026-01-23","current":-2.126024,"twenty":-1.604426,"median":-1.301745,"eighty":-1.139778,"marketCap":55715242.29},{"date":"2026-01-30","current":-1.941152,"twenty":-1.628255,"median":-1.302604,"eighty":-1.139778,"marketCap":52080707.44},{"date":"2026-02-06","current":-1.941152,"twenty":-1.667996,"median":-1.306954,"eighty":-1.139778,"marketCap":51841289.27},{"date":"2026-02-13","current":-2.033588,"twenty":-1.667996,"median":-1.314224,"eighty":-1.139778,"marketCap":55307671.3},{"date":"2026-02-20","current":-2.033588,"twenty":-1.700295,"median":-1.314224,"eighty":-1.139778,"marketCap":55018878.78},{"date":"2026-02-27","current":-2.126024,"twenty":-1.737391,"median":-1.314257,"eighty":-1.139778,"marketCap":57875023.78},{"date":"2026-03-06","current":-1.59778,"twenty":-1.736805,"median":-1.314257,"eighty":-1.139778,"marketCap":51986127.68},{"date":"2026-03-13","current":-1.673865,"twenty":-1.736805,"median":-1.319888,"eighty":-1.139778,"marketCap":55303748.49},{"date":"2026-03-20","current":-1.521695,"twenty":-1.736805,"median":-1.319888,"eighty":-1.139778,"marketCap":49962166.26},{"date":"2026-03-27","current":-1.521695,"twenty":-1.713375,"median":-1.332069,"eighty":-1.139778,"marketCap":48917114.43},{"date":"2026-04-02","current":-1.59778,"twenty":-1.702101,"median":-1.347386,"eighty":-1.139778,"marketCap":51407670.21},{"date":"2026-04-10","current":-1.673865,"twenty":-1.688914,"median":-1.356879,"eighty":-1.142125,"marketCap":55135202.69},{"date":"2026-04-17","current":-1.559737,"twenty":-1.68253,"median":-1.356879,"eighty":-1.143689,"marketCap":52080849.71},{"date":"2026-04-24","current":-1.521695,"twenty":-1.677331,"median":-1.356879,"eighty":-1.150417,"marketCap":50766553.27},{"date":"2026-05-01","current":-1.44561,"twenty":-1.673865,"median":-1.359167,"eighty":-1.154902,"marketCap":48390418.94},{"date":"2026-05-08","current":-1.44561,"twenty":-1.673865,"median":-1.359542,"eighty":-1.154902,"marketCap":48807789.37},{"date":"2026-05-15","current":-1.59778,"twenty":-1.673865,"median":-1.364534,"eighty":-1.154902,"marketCap":53762307.86},{"date":"2026-05-22","current":-1.59778,"twenty":-1.673865,"median":-1.374883,"eighty":-1.16211,"marketCap":53045783.62},{"date":"2026-05-29","current":-1.521695,"twenty":-1.673865,"median":-1.384154,"eighty":-1.167441,"marketCap":50747653.92},{"date":"2026-06-05","current":-1.521695,"twenty":-1.671517,"median":-1.396235,"eighty":-1.168228,"marketCap":50613583.01},{"date":"2026-06-12","current":-1.521695,"twenty":-1.667996,"median":-1.40486,"eighty":-1.168228,"marketCap":49583326.11},{"date":"2026-06-18","current":-1.521695,"twenty":-1.667996,"median":-1.40486,"eighty":-1.168228,"marketCap":49802798.43},{"date":"2026-06-26","current":-1.44561,"twenty":-1.667996,"median":-1.411154,"eighty":-1.168228,"marketCap":46592476.99},{"date":"2026-07-02","current":-1.59778,"twenty":-1.667996,"median":-1.411154,"eighty":-1.168228,"marketCap":51596907.45},{"date":"2026-07-10","current":-1.44561,"twenty":-1.667996,"median":-1.411154,"eighty":-1.168228,"marketCap":46750976.81},{"date":"2026-07-17","current":-1.521695,"twenty":-1.667996,"median":-1.411154,"eighty":-1.168228,"marketCap":49628455.51},{"date":"2026-07-24","current":-1.44561,"twenty":-1.665351,"median":-1.418632,"eighty":-1.178269,"marketCap":46943260.37},{"date":"2026-07-31","current":-1.180743,"twenty":-1.652958,"median":-1.411154,"eighty":-1.176261,"marketCap":38554562.6},{"date":"2026-08-07","current":-1.117386,"twenty":-1.632576,"median":-1.411154,"eighty":-1.168228,"marketCap":36614091.87},{"date":"2026-08-14","current":-1.02427,"twenty":-1.628255,"median":-1.411154,"eighty":-1.168228,"marketCap":33686136.68},{"date":"2026-08-21","current":-0.931155,"twenty":-1.628255,"median":-1.411154,"eighty":-1.164513,"marketCap":30883228.2},{"date":"2026-08-28","current":-0.838039,"twenty":-1.628255,"median":-1.40486,"eighty":-1.152659,"marketCap":28080812.11}],"updateTime":1788199210542},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RADX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662713512","title":"Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662713512","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662713512?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:00","pubTimestamp":1787742000,"startTime":"0","endTime":"0","summary":"Doses first patient at 70 mCi dose of RV-01, the first radiopharmaceutical therapeutic developed in Company’s joint venture with MD Anderson Cancer CenterSYDNEY, Aug.  26, 2026 (GLOBE NEWSWIRE) -- Rad","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351185/0/en/radiopharm-theranostics-doses-first-patient-in-second-cohort-of-phase-1-2a-clinical-trial-of-betabart-rv-01-in-b7-h3-expressing-solid-tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4144","SMC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286629","title":"Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286629","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286629?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223600,"startTime":"0","endTime":"0","summary":"Advancing RAD202 Phase 1 trial to next dose level of 180mCi in patients with HER2+ advanced solid tumors Previous diagnostic study of RAD202 in ten HER2-positive breast cancer patients demonstrated cl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348199/0/en/radiopharm-theranostics-receives-positive-recommendation-from-data-safety-and-monitoring-committee-to-advance-to-cohort-4-in-177lu-rad202-phase-1-heat-clinical-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSMC","RADX","HEAT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482660","title":"Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482660","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482660?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:40","pubTimestamp":1786966835,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) announced that it has scheduled an End-of-Phase 2 meeting with the FDA for October 1, to align on the design of a pivotal Phase 3...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487966","title":"Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487966?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:30","pubTimestamp":1786966200,"startTime":"0","endTime":"0","summary":"RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U.S. FDA scheduled for October 1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3345992/0/en/radiopharm-theranostics-to-meet-with-u-s-fda-to-align-on-pivotal-phase-3-trial-design-for-rad-101-in-diagnosis-of-brain-metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368936","title":"Press Release: Radiopharm Theranostics Reports Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368936","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368936?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:00","pubTimestamp":1785495600,"startTime":"0","endTime":"0","summary":"endpoint, with 93% of patients treated with RAD 101 achieving concordance. with MRI imaging. Additionally, an interim analysis of 14 patients from. -- The Company anticipates the initiation of a Phase 3, multi-center,","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MEDX","NVIB","RADX","ODD","HYLG","BK4139","RAD.AU","IE0009354923.USD","GDOC","BK4183","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653080335","title":"NASDAQ Trade Halt Continues Volatility Trading Pause at 09:37 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2653080335","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653080335?lang=en_us&edition=fundamental","pubTime":"2026-07-24 21:37","pubTimestamp":1784900234,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUESVOLATILITY TRADING PAUSE AT 09:37 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nAQN2MBIQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653166081","title":"Radiopharm announces $4.1M registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2653166081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653166081?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:30","pubTimestamp":1784892624,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) announced that it has entered into a securities purchase agreement, or SPA, with certain U.S. accredited institutional investors ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-announces-4-1m-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-announces-4-1m-registered-direct-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653081758","title":"Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2653081758","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653081758?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:15","pubTimestamp":1784891700,"startTime":"0","endTime":"0","summary":"NEW YORK and SYDNEY, July  24, 2026  (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/24/3332785/0/en/Radiopharm-Theranostics-Announces-Concurrent-US-4-1-Million-Registered-Direct-Offering-and-Up-To-Additional-A-12-7-US-8-9-Million-Australian-Placement-and-Share-Purchase-Plan.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752838","title":"Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752838","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752838?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:05","pubTimestamp":1784718300,"startTime":"0","endTime":"0","summary":"First RECIST-confirmed durable Partial Response at current highest dose level #3 (90mCi) with the patient remaining progression free beyond seven months Second patient dosed remains progression free o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/22/3331243/0/en/Radiopharm-Theranostics-Achieves-Confirmed-Durable-Partial-Response-in-Ongoing-Phase-1-Trial-of-RAD204-in-Patients-with-Advanced-Solid-Tumors-Post-Immunotherapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK4157","IE00B7SZL793.SGD","POST","RADX","LU1815336091.USD","IE00B66KJ199.SGD","BK4212","AEIS","IE00B19Z4B17.USD","LU0757428866.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754008","title":"Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754008","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653754008?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:00","pubTimestamp":1784718000,"startTime":"0","endTime":"0","summary":"RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint. 14 patients with available data from six-month follow-up and biopsy show preliminar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/22/3331214/0/en/Radiopharm-Theranostics-Announces-Positive-Phase-2b-Trial-Results-of-RAD-101-for-Diagnosis-of-Brain-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRS","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653578114","title":"NASDAQ Trade Halt Halt News Pending at 07:56 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2653578114","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653578114?lang=en_us&edition=fundamental","pubTime":"2026-07-22 07:56","pubTimestamp":1784678215,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:56 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nAQN2MB4NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815964","title":"Radiopharm Theranostics Ltd : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640815964?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:11","pubTimestamp":1780567878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nFWN42C0BC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RADX","RAD.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640159456","title":"Radiopharm initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2640159456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640159456?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:10","pubTimestamp":1780567820,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of Radiopharm (RADX) with a Buy rating and $6 price target The company seeks to expand the cancer patient popula...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629783311","title":"Radiopharm Theranostics Reports Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629783311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629783311?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942000,"startTime":"0","endTime":"0","summary":"Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279721/0/en/Radiopharm-Theranostics-Reports-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","RADX","BK4213","DSMC","RAD","BK4139","BK4128","ODD","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628172897","title":"Radiopharm announces new data from Phase 0/1 HEAT trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628172897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628172897?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:08","pubTimestamp":1776686939,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) Theranostics announced that new data from the ongoing Phase 0/1 HEAT trial, evaluating 177Lu-RAD202, a first-in-class HER2-target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-announces-new-data-from-phase-0-1-heat-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-announces-new-data-from-phase-0-1-heat-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139","HEAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628984742","title":"Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628984742","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628984742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"177Lu-RAD202 demonstrated encouraging tumor uptake and a favorable safety profile in the lowest dose cohort Data Safety and Monitoring Committee Recently Approved Advancing 177Lu-RAD202 to Next Highes","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276868/0/en/Radiopharm-Theranostics-Presents-Initial-Findings-from-Phase-1-First-in-Human-HEAT-Clinical-Trial-for-177Lu-RAD202-in-HER2-Solid-Tumors-at-American-Association-for-Cancer-Research-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAT","BK4107","BK4117","RADX","AFG","RAD","BK4139","BK4128","DSMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949153","title":"Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949153","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949153?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:00","pubTimestamp":1775646000,"startTime":"0","endTime":"0","summary":"Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to progress Phase 1 to the next dose level of 130mCi in patients with HER2+ advanced solid tumorsSYDNEY, April  08, 20","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3269961/0/en/Radiopharm-Theranostics-Advances-to-Cohort-3-in-177Lu-RAD202-Phase-1-Dose-Escalating-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSMC","BK4139","RADX","RAD","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622965458","title":"Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2622965458","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622965458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 03:45","pubTimestamp":1774554316,"startTime":"0","endTime":"0","summary":"Analyst Michael Okunewitch of Maxim Group maintained a Buy rating on Radiopharm Theranostics Limited Sponsored ADR, with a price target of $15.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-radx-driven-by-promising-rad-101-phase-2b-imaging-data-and-clear-2026-clinical-milestones-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-radx-driven-by-promising-rad-101-phase-2b-imaging-data-and-clear-2026-clinical-milestones-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAD","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066089","title":"Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066089","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066089?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":"90% of patients dosed with RAD 101 and evaluable at interim analysis achieved concordance with MRI imaging (the primary endpoint) First five patients with available data from six-month follow-up and b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261071/0/en/Radiopharm-Theranostics-Achieves-Primary-Endpoint-In-90-of-Patients-At-Second-Interim-Analysis-of-RAD-101-Phase-2b-Imaging-Trial-in-Brain-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRS","RADX","RAD","BK4139","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617631279","title":"Analysts Are Bullish on These Healthcare Stocks: Schrodinger (SDGR), Radiopharm Theranostics Limited Sponsored ADR (RADX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631279","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617631279?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:31","pubTimestamp":1772814704,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Schrodinger (SDGR – Research Report), Radiopharm The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-schrodinger-sdgr-radiopharm-theranostics-limited-sponsored-adr-radx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-schrodinger-sdgr-radiopharm-theranostics-limited-sponsored-adr-radx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","RADX","BK4588","SDGR","LU0029874061.USD","BK4167","XBI","BK4112","BLSG","BLSX","LU0128526141.USD","BK4581","BK4137","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}